Stratos Wealth Partners, Ltd. Celldex Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$1.55 - $3.07 $38,750 - $76,750	-25,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.75 $51,249 - $68,750	25,000 New	25,000 $53,000
Q3 2019 Nov 12, 2019	SELL	$2.05 - $2.75 $51,249 - $68,750	-25,000 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$2.43 - $5.09 $12,150 - $25,450	5,000 Added 25.0%	25,000 $67,000
Q1 2019 May 07, 2019	BUY	$3.45 - $10.35 $69,000 - $207,000	20,000 New	20,000 $98,000

199

66M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.